What Is Epanova?
Epanova is an FDA-approved prescription omega-3 fatty acid product containing highly purified EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) ethyl esters. It treats severe hypertriglyceridemia (triglyceride levels above 500 mg/dL) in adults, reducing cardiovascular risk when used with diet.[1]
How Does Epanova Lower Triglycerides?
Epanova works by delivering high doses of EPA and DHA, which the body converts into active metabolites. These bind to peroxisome proliferator-activated receptor-alpha (PPAR-alpha) in liver cells, activating genes that boost beta-oxidation of fatty acids. This process breaks down triglycerides for energy, cutting liver production and very-low-density lipoprotein (VLDL) secretion—the main triglyceride carriers in blood. Clinical trials showed 4g daily doses reduce triglycerides by 20-30% on average.[1][2]
Role of EPA vs. DHA
EPA primarily suppresses triglyceride synthesis by inhibiting acyl-CoA:1,2-diacylglycerol acyltransferase (DGAT), an enzyme in the final step of triglyceride assembly. DHA complements this by enhancing fatty acid clearance and reducing inflammation via resolvins and protectins. Unlike some omega-3s, Epanova's ethyl ester form absorbs efficiently without meals, reaching peak plasma levels faster.[2]
How It Differs from Fish Oil or Lovaza
Epanova's concentrated, purified EPA/DHA (EPA:DHA ratio near 1:1) avoids contaminants like mercury. Compared to OTC fish oil, it delivers prescription-strength doses with proven triglyceride reduction in studies. Lovaza (another EPA/DHA ethyl ester) works similarly but Epanova uses a higher EPA proportion in some formulations, potentially better for anti-inflammatory effects. Neither raises LDL cholesterol much at high doses, unlike fibrates.[1][3]
What Happens in the Body After Dosing?
Taken as 4 capsules (1g each) daily, Epanova incorporates into cell membranes within hours. Peak effects on triglycerides occur after 4-6 weeks. It mildly lowers blood pressure and platelet aggregation via eicosanoid modulation but does not significantly alter HDL or total cholesterol.[2]
Common Patient Questions on Effectiveness and Limits
Patients often ask if it prevents heart attacks—trials confirm triglyceride drops but mixed CV outcomes; it's adjunctive, not standalone. Side effects include fishy burps (less than triglycerides), bleeding risk at high doses with anticoagulants, and rare liver enzyme rises. Not for triglycerides under 500 mg/dL or as vitamin/mineral substitute.[1]
[1]: FDA Label for Epanova
[2]: Mechanism Review in Journal of Clinical Lipidology
[3]: DrugPatentWatch.com - Epanova vs. Competitors